PA
MDT icon

Promethium Advisors’s Medtronic MDT Stock Holding History

Promethium Advisors’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,270
Closed -$220K – 118
2025
Q4 		$220K Hold
2,270
– – 0.12% 107
2025
Q3 		$218K Buy
+2,270
New +$209K 0.12% 110
2025
Q2 		– Sell
-2,270
Closed -$206K – 124
2025
Q1 		$206K Buy
+2,270
New +$203K 0.13% 112

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Promethium Advisors's MDT Position: Q1 2026 in Review

Promethium Advisors sold out of Medtronic (MDT) in Q1 2026, closing a stake of 2,270 shares — an estimated $220K sold.

Promethium Advisors first reported a position in MDT in Q1 2025 and held it in 3 quarters. The position peaked at $220K in Q4 2025. 2,230 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Promethium Advisors reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
  • Promethium Advisors sold 2,270 Medtronic shares in Q1 2026, an estimated $220K.
  • Promethium Advisors first reported a position in Medtronic in Q1 2025 and held it in 3 quarters.
  • Promethium Advisors's Medtronic position peaked at $220K in Q4 2025.
  • 2,230 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Promethium Advisors's 13F filing for Q1 2026, filed 22 Apr 2026.